KADOCH CIGALL 4
4 · Foghorn Therapeutics Inc. · Filed Jul 14, 2021
Insider Transaction Report
Form 4
KADOCH CIGALL
Director10% Owner
Transactions
- Award
Stock Option (right to buy)
2021-07-13+12,530→ 12,530 totalExercise: $9.40From: 2022-07-13Exp: 2031-07-12→ Common Stock (12,530 underlying)
Footnotes (1)
- [F1]The options will vest in full on the first anniversary of the date of grant, subject to the director's continued service on our Board of Directors.